Biotech Biosyngen’s BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma July 16, 2024
Biotech EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round July 16, 2024
Biotech Rznomics Inc. Secures Australian Clinical Trial Notification for RHO-targeted Splicing Ribozyme-based RNA Editing Therapy for Retinitis Pigmentosa July 15, 2024
Biotech CPHI & PMEC Shenzhen 2024: Fostering New Opportunities in Asia and China’s Greater Bay Area July 15, 2024
Biotech Nona Biosciences Enters into Collaboration Agreement with Alaya.bio to Advance CAR-T Cell Therapy July 15, 2024
Biotech AusperBio Secures $37 Million in Series A Financing to Advance AHB-137 Clinical Development for HBV Cure July 15, 2024
Biotech Global High-Throughput Screening (HTS) Market to Reach USD 50.2 Billion by 2029: Opportunities, Challenges, and Growth Drivers | MarketsandMarkets™ July 13, 2024
Biotech 3D Cell Culture Market to Transcend USD 11.79 Billion Valuation by 2031, Rising Demand for Regenerative Medicine to Augment Market Development | SkyQuest Technology July 13, 2024
Search
Biotech
July 16, 2024
July 16, 2024
July 16, 2024
July 15, 2024
July 15, 2024
July 15, 2024
July 15, 2024
July 13, 2024
July 13, 2024
July 13, 2024
